
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Stimuli-Responsive mRNA Vaccines to Induce Robust CD8+ T Cell Response via ROS-Mediated Innate Immunity Boosting
Linying Dong, Xuqian Deng, Yan Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 28, pp. 19218-19228
Closed Access | Times Cited: 9
Linying Dong, Xuqian Deng, Yan Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 28, pp. 19218-19228
Closed Access | Times Cited: 9
Showing 9 citing articles:
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Reprogramming the Tumor Immune Microenvironment Through Activatable Photothermal Therapy and GSH depletion Using Liposomal Gold Nanocages to Potentiate AntiāMetastatic Immunotherapy
Jiayi Li, Kaifan Zheng, Luping Lin, et al.
Small (2024)
Closed Access | Times Cited: 4
Jiayi Li, Kaifan Zheng, Luping Lin, et al.
Small (2024)
Closed Access | Times Cited: 4
Bisboronic Ester-Enabled Redox-Targeted Cancer Therapy: A Cascade ROS Consumption Approach for Efficient Elimination of Cancer Cells
Silin Huang, Yue Cui, Boqiang Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Silin Huang, Yue Cui, Boqiang Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Improving the Efficacy of Cancer mRNA Vaccines
Ameya R. Kirtane, Giovanni Traverso
The Cancer Journal (2025) Vol. 31, Iss. 2
Closed Access
Ameya R. Kirtane, Giovanni Traverso
The Cancer Journal (2025) Vol. 31, Iss. 2
Closed Access
Self-Assembled Glycopeptide as a Biocompatible mRNA Vaccine Platform Elicits Robust Antitumor Immunity
Yang Zhou, Ye Wu, Shengjie Sun, et al.
ACS Nano (2025)
Closed Access
Yang Zhou, Ye Wu, Shengjie Sun, et al.
ACS Nano (2025)
Closed Access
Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo
Shiqi Wu, Kexin Su, Xinxin Yan, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 395-401
Closed Access | Times Cited: 3
Shiqi Wu, Kexin Su, Xinxin Yan, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 395-401
Closed Access | Times Cited: 3
Interaction design in mRNA delivery systems
Mengyao Yu, Lixin Lin, Dezhong Zhou, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 413-426
Closed Access | Times Cited: 2
Mengyao Yu, Lixin Lin, Dezhong Zhou, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 413-426
Closed Access | Times Cited: 2
Advances in COVID-19 and Cancer Research
Laura Franza, Rossella Cianci
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4143-4143
Open Access
Laura Franza, Rossella Cianci
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4143-4143
Open Access
A review of innovative design strategies: Artificial antigen presenting cells in cancer immunotherapy
Rabiya Altaf, Aditya Mohan, Naveen Palani, et al.
International Journal of Pharmaceutics (2024), pp. 125053-125053
Closed Access
Rabiya Altaf, Aditya Mohan, Naveen Palani, et al.
International Journal of Pharmaceutics (2024), pp. 125053-125053
Closed Access